Evidence map›Paper›PMID 10615295›Full record

ArticleOccupational and environmental medicine1999

Study of cancer incidence among 6363 male workers in four Norwegian ferromanganese and silicomanganese producing plants.

A Hobbesland, H Kjuus, D S Thelle

Open access · bronzeAbstract read
In one paragraph

Article in Occupational and environmental medicine, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

A HobbeslandTelemark Central Hospital, Department of Occupational and Environmental Medicine, Skien, Norway.
H Kjuus
D S Thelle
Telemark Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesLittle has been known about the risk of cancer associated with occupational exposure to manganese. The objective of this study was therefore to examine the associations between duration of specific work and cancer incidence among employees in four Norwegian ferromanganese and silicomanganese producing plants.

methodsAmong men first employed in 1933-91 and with at least 6 months in these plants, the incident cases of cancer during 1953-91 were obtained from The Cancer Registry of Norway. The numbers of various cancers were compared with expected figures calculated from age and calendar time specific rates for Norwegian men during the same period. Internal comparisons of rates were performed with Poisson regression analysis. The final cohort comprised 6363 men.

resultsA total of 607 cases of cancer were observed against 596 cases expected (standardised incidence ratio (SIR) 1.02). Internal comparisons of rates showed a positive trend between the rate of all cancers and duration of furnace work. A slightly weaker trend was also found for duration of blue collar non-furnace work when lags of 25 or 30 years were applied in the analyses. However, several results indicated that the incidence of all cancers among the non-furnace workers decreased during the period of active employment.

conclusionsFurnace and non-furnace workers may have exposures that increase the incidence of several cancers. The low incidence of cancer among non-furnace workers during the period of ongoing exposure cannot be explained. As this study cannot identify any causal factors, the role of exposure to manganese remains unclear.

Indexed as

Ferrous CompoundsHumansIncidenceMaleManganeseNeoplasmsNorwayOccupational DiseasesOccupational ExposureRegression AnalysisTime FactorsFerrous CompoundsManganese

Identifiers

PMID10615295
PMCPMC1757793
OpenAlexW2141073080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.